NASDAQ:CME - CME Group Stock Price, News, Headlines & Rumors Sign in or create an account to add this stock to your watchlist. Get Started $168.48 +0.81 (+0.48 %) (As of 08/16/2018 04:00 PM ET)Previous Close$167.67Today's Range$168.01 - $169.5552-Week Range$123.88 - $174.36Volume1.31 million shsAverage Volume1.60 million shsMarket Capitalization$55.65 billionP/E Ratio35.41Dividend Yield1.68%Beta0.64 Company ProfileAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions, as well as provides hosting, connectivity, and customer support for electronic trading through its co-location services. It also provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps; and regulatory reporting solutions for market participants through its repository services in the United States, the United Kingdom, Canada, and Australia. In addition, the company offers a range of market data services, including live quotes, delayed quotes, market reports, and historical data services, as well as index services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. Receive CME News and Ratings via Email Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Security & commodity brokers, dealers, exchanges & services Sub-IndustrySpecialized Finance SectorFinance SymbolNASDAQ:CME CUSIP12572Q10 Webwww.cmegroup.com Phone312-930-1000 Debt Debt-to-Equity Ratio0.15 Current Ratio1.08 Quick Ratio1.08 Price-To-Earnings Trailing P/E Ratio35.41 Forward P/E Ratio25.22 P/E Growth3.07 Sales & Book Value Annual Sales$3.64 billion Price / Sales15.69 Cash Flow$5.5512 per share Price / Cash30.35 Book Value$66.07 per share Price / Book2.55 Profitability EPS (Most Recent Fiscal Year)$4.77 Net Income$4.06 billion Net Margins111.45% Return on Equity9.03% Return on Assets2.75% Miscellaneous Employees2,830 Outstanding Shares339,520,000Market Cap$55.65 billion CME Group (NASDAQ:CME) Frequently Asked Questions What is CME Group's stock symbol? CME Group trades on the NASDAQ under the ticker symbol "CME." How often does CME Group pay dividends? What is the dividend yield for CME Group? CME Group announced a quarterly dividend on Wednesday, August 8th. Stockholders of record on Monday, September 10th will be given a dividend of $0.70 per share on Tuesday, September 25th. This represents a $2.80 annualized dividend and a dividend yield of 1.66%. The ex-dividend date is Friday, September 7th. View CME Group's Dividend History. How were CME Group's earnings last quarter? CME Group Inc (NASDAQ:CME) issued its earnings results on Thursday, July, 26th. The financial services provider reported $1.74 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.72 by $0.02. The financial services provider had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The firm's quarterly revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.22 earnings per share. View CME Group's Earnings History. When is CME Group's next earnings date? CME Group is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for CME Group. What price target have analysts set for CME? 13 Wall Street analysts have issued 12-month target prices for CME Group's stock. Their forecasts range from $133.00 to $197.00. On average, they expect CME Group's share price to reach $169.5385 in the next year. This suggests a possible upside of 0.6% from the stock's current price. View Analyst Price Targets for CME Group. What is the consensus analysts' recommendation for CME Group? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CME Group. Who are some of CME Group's key competitors? Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price Group (TROW), DEUTSCHE BOERSE/ADR (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG). Who are CME Group's key executives? CME Group's management team includes the folowing people: Mr. Terrence A. Duffy, Chairman & CEO (Age 60)Mr. Bryan Thomas Durkin, Pres (Age 57)Mr. John W. Pietrowicz, Sr. MD & CFO (Age 53)Mr. Kevin Kometer, Sr. MD & Chief Information Officer (Age 53)Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 54) Has CME Group been receiving favorable news coverage? Press coverage about CME stock has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a coverage optimism score of 0.09 on Accern's scale. They also gave news headlines about the financial services provider an impact score of 47.88 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for CME Group. Who are CME Group's major shareholders? CME Group's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.49%), Edgewood Management LLC (2.31%), Janus Henderson Group PLC (1.81%), Bank of New York Mellon Corp (1.10%), Wells Fargo & Company MN (1.09%) and Waddell & Reed Financial Inc. (1.07%). Company insiders that own CME Group stock include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group. Which major investors are selling CME Group stock? CME stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Millennium Management LLC, Waddell & Reed Financial Inc., PointState Capital LP, Wells Fargo & Company MN, Russell Investments Group Ltd. and Point72 Asset Management L.P.. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group. Which major investors are buying CME Group stock? CME stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Renaissance Technologies LLC, Unigestion Holding SA, KAMES CAPITAL plc, Standard Life Aberdeen plc, Robeco Institutional Asset Management B.V., Edgewood Management LLC and Vontobel Asset Management Inc.. View Insider Buying and Selling for CME Group. How do I buy shares of CME Group? Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CME Group's stock price today? One share of CME stock can currently be purchased for approximately $168.48. How big of a company is CME Group? CME Group has a market capitalization of $55.65 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe. How can I contact CME Group? CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected] MarketBeat Community Rating for CME Group (NASDAQ CME)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 466 (Vote Outperform)Underperform Votes: 513 (Vote Underperform)Total Votes: 979MarketBeat's community ratings are surveys of what our community members think about CME Group and other stocks. Vote "Outperform" if you believe CME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CME will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/16/2018 by MarketBeat.com StaffFeatured Article: Dividend Stocks - Are They Right For You?